Why the study?
Does intravenous vasopressin V1 receptor antagonist alter blood pressure regulation during hypovolemic hypotension in normal subjects?
Population
12 normal subjects
Comparison
Intravenous administration of vasopressin V1… vs Lower body negative pressure-induced hypotension…
Design
Other
Authors
Loading...
Vasopressin V1 blockade does not worsen LBNP hypotension in healthy subjects; challenges animal data and leaves open its role in clinical hypovolemia.
Does intravenous vasopressin V1 receptor antagonist alter blood pressure regulation during hypovolemic hypotension in normal subjects?
In contrast to animal studies, vasopressin does not appear to contribute to the maintenance of blood pressure during hypovolemic hypotension in humans.
Hirsch et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: